Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AUPH

Aurinia Pharmaceuticals (AUPH)

Aurinia Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AUPH
DateTimeSourceHeadlineSymbolCompany
24/09/202422:10Business WireAurinia Announces Japan Approval of LUPKYNIS® (Voclosporin) to Treat Lupus NephritisNASDAQ:AUPHAurinia Pharmaceuticals Inc
21/09/202406:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUPHAurinia Pharmaceuticals Inc
13/09/202420:00Business WireAurinia to Participate in 2024 Cantor Fitzgerald Global Healthcare ConferenceNASDAQ:AUPHAurinia Pharmaceuticals Inc
13/09/202406:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AUPHAurinia Pharmaceuticals Inc
13/09/202406:05Business WireAurinia Announces Board RestructuringNASDAQ:AUPHAurinia Pharmaceuticals Inc
05/09/202420:00Business WireAurinia Announces First Participant Dosed in AUR200 Single Ascending Dose TrialNASDAQ:AUPHAurinia Pharmaceuticals Inc
28/08/202420:00Business WireAurinia to Participate in H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:AUPHAurinia Pharmaceuticals Inc
09/08/202406:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUPHAurinia Pharmaceuticals Inc
01/08/202420:07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AUPHAurinia Pharmaceuticals Inc
01/08/202420:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AUPHAurinia Pharmaceuticals Inc
01/08/202420:00Business WireAurinia Pharmaceuticals Reports Second Quarter and Six Months 2024 Financial and Operational ResultsNASDAQ:AUPHAurinia Pharmaceuticals Inc
19/07/202420:00Business WireAurinia Pharmaceuticals to Release Second Quarter Financial and Operational Results on August 1, 2024NASDAQ:AUPHAurinia Pharmaceuticals Inc
02/07/202420:00Business WireAurinia to Participate in Upcoming Investor Healthcare ConferencesNASDAQ:AUPHAurinia Pharmaceuticals Inc
15/06/202407:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AUPHAurinia Pharmaceuticals Inc
15/06/202402:16Business WireAurinia Announces 2024 Annual General Meeting ResultsNASDAQ:AUPHAurinia Pharmaceuticals Inc
05/06/202420:00Business WireAurinia Presents Safety and Efficacy Profile of LUPKYNIS® for People with Lupus Nephritis at European Alliance of Associations for Rheumatology (EULAR) Congress 2024NASDAQ:AUPHAurinia Pharmaceuticals Inc
05/06/202407:30Business WireAurinia Addresses Dubious Proposals Put Forth by Lucien SelceNASDAQ:AUPHAurinia Pharmaceuticals Inc
05/06/202407:25Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AUPHAurinia Pharmaceuticals Inc
04/06/202408:30Business WireAurinia Provides Update on Proxy StatementNASDAQ:AUPHAurinia Pharmaceuticals Inc
30/05/202420:00Business WireAurinia Will Attend 2024 Jefferies Global Healthcare ConferenceNASDAQ:AUPHAurinia Pharmaceuticals Inc
23/05/202406:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUPHAurinia Pharmaceuticals Inc
23/05/202406:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUPHAurinia Pharmaceuticals Inc
23/05/202406:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUPHAurinia Pharmaceuticals Inc
23/05/202406:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUPHAurinia Pharmaceuticals Inc
23/05/202406:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUPHAurinia Pharmaceuticals Inc
14/05/202420:00Business WireAnalysis Showing LUPKYNIS® is a Cost-Effective Treatment for Lupus Nephritis Presented at National Kidney Foundation’s Spring Clinical Meeting 2024NASDAQ:AUPHAurinia Pharmaceuticals Inc
09/05/202420:00Business WireAurinia Presents Data Reinforcing LUPKYNIS® Safety and Efficacy for People with Lupus Nephritis at Congress of Clinical Rheumatology East 2024NASDAQ:AUPHAurinia Pharmaceuticals Inc
07/05/202420:00Business WireAurinia Will Attend 2024 RBC Capital Markets Global Healthcare ConferenceNASDAQ:AUPHAurinia Pharmaceuticals Inc
02/05/202420:00Business WireAurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational ResultsNASDAQ:AUPHAurinia Pharmaceuticals Inc
01/05/202420:00Business WireAurinia Underscores Enduring Commitment to People Living with Lupus Nephritis Through Innovative Advocacy and Education Initiatives for Lupus Awareness MonthNASDAQ:AUPHAurinia Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:AUPH